WINTON GROUP Ltd - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 65 filers reported holding ENZO BIOCHEM INC in Q3 2021. The put-call ratio across all filers is 3.06 and the average weighting 0.4%.

Quarter-by-quarter ownership
WINTON GROUP Ltd ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q3 2021$138,000
+15.0%
39,041
+3.1%
0.01%
+33.3%
Q2 2021$120,000
-9.1%
37,878
-1.1%
0.01%
-25.0%
Q1 2021$132,000
+34.7%
38,306
-2.0%
0.01%
+14.3%
Q4 2020$98,000
-22.8%
39,086
-34.9%
0.01%
+75.0%
Q3 2020$127,000
-42.0%
60,047
-38.6%
0.00%
-33.3%
Q2 2020$219,000
+73.8%
97,742
+95.7%
0.01%
+100.0%
Q1 2020$126,000
+5.9%
49,952
+9.9%
0.00%
+50.0%
Q4 2019$119,000
-33.5%
45,432
-8.4%
0.00%0.0%
Q3 2019$179,00049,6050.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q3 2021
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,392,642$6,939,00011.21%
VIEX Capital Advisors, LLC 1,435,130$4,162,0007.44%
HARBERT FUND ADVISORS, INC. 5,175,913$15,010,0006.29%
Potomac Capital Management, Inc. 496,805$1,441,0001.24%
AMH Equity Ltd 30,000$87,0000.09%
Corsair Capital Management 75,026$218,0000.05%
RBF Capital, LLC 250,359$730,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$74,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 539,954$1,566,0000.04%
Cutter & CO Brokerage, Inc. 25,777$75,0000.02%
View complete list of ENZO BIOCHEM INC shareholders